Neuren Pharmaceuticals Ltd. (NURPF)
14.28
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Neuren Pharmaceuticals Free Cash Flow : 6.384M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.384M |
| December 31, 2025 | 82.16M |
| June 30, 2025 | 87.45M |
| December 31, 2024 | -7.456M |
| June 30, 2024 | 77.84M |
| December 31, 2023 | 121.67M |
| June 30, 2023 | 36.61M |
| December 31, 2022 | 2.113M |
| June 30, 2022 | -6.987M |
| December 31, 2021 | -7.546M |
| June 30, 2021 | -6.866M |
| December 31, 2020 | -5.501M |
| June 30, 2020 | -5.997M |
| December 31, 2019 | -8.200M |
| June 30, 2019 | 1.938M |
| December 31, 2018 | 4.456M |
| June 30, 2018 | -4.643M |
| December 31, 2017 | -4.267M |
| June 30, 2017 | -5.696M |
| December 31, 2016 | -9.164M |
| June 30, 2016 | -12.03M |
| Date | Value |
|---|---|
| December 31, 2015 | -9.473M |
| June 30, 2015 | -7.004M |
| December 31, 2014 | -5.798M |
| June 30, 2014 | -6.507M |
| December 31, 2013 | -6.561M |
| June 30, 2013 | -5.221M |
| December 31, 2012 | -3.068M |
| June 30, 2012 | -2.828M |
| December 31, 2011 | -3.307M |
| June 30, 2011 | -2.346M |
| December 31, 2010 | -2.730M |
| June 30, 2010 | -1.478M |
| December 31, 2009 | -1.116M |
| June 30, 2009 | -3.271M |
| December 31, 2008 | -7.834M |
| June 30, 2008 | -10.75M |
| December 31, 2007 | -9.636M |
| June 30, 2007 | -8.063M |
| December 31, 2006 | -6.767M |
| June 30, 2006 | -6.300M |
| December 31, 2005 | -6.256M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Percheron Therapeutics Ltd. | -5.655M |
| Starpharma Holdings Ltd. | -2.457M |
| Mayne Pharma Group Ltd. | 8.640M |
| Acrux Ltd. | 0.7159M |
| Zelira Therapeutics Ltd. | -- |
Free Cash Flow Related Metrics
| Free Cash Flow Yield | 0.34% |